Book chapter · 2006

A Pharmaceutical Company User's Perspective on the Potential of High Content Screening in Drug Discovery

Ann F. Hoffman, Ralph J. Garippa

Humana Press eBooks, 356, 19–32 · Published 20 September 2006 · DOI 10.1385/1-59745-217-3:19

View at the publisherCite this paper

In brief

“A Pharmaceutical Company User's Perspective on the Potential of High Content Screening in Drug Discovery” is a 2006 book chapter by Ann F. Hoffman and Ralph J. Garippa, published in Humana Press eBooks. OpenAlex counts 34 citations as of 19 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
34
Most cited in
2015 (3)
Field-weighted impact
6.20
References
11
Authors
2

Abstract

It is early to fully reflect on the state of the art in high content screening (HCS), because it is still a relatively new approach in drug discovery. Although the development of the first microscopes are a century old and the first confocal microscope is only 20 yr old, the fluorescent probes used within HCS… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Hoffman, A. F., & Garippa, R. J. (2006). A Pharmaceutical Company User's Perspective on the Potential of High Content Screening in Drug Discovery. Humana Press eBooks, 356, 19–32. https://doi.org/10.1385/1-59745-217-3:19

MLA 9

Hoffman, Ann F., and Ralph J. Garippa. “A Pharmaceutical Company User's Perspective on the Potential of High Content Screening in Drug Discovery.” Humana Press eBooks, vol. 356, 2006, pp. 19–32. https://doi.org/10.1385/1-59745-217-3:19.

Chicago

Hoffman, Ann F. and Ralph J. Garippa. 2006. “A Pharmaceutical Company User's Perspective on the Potential of High Content Screening in Drug Discovery.” Humana Press eBooks 356: 19–32. https://doi.org/10.1385/1-59745-217-3:19.

Harvard

Hoffman, A. F. and Garippa, R. J. (2006) ‘A Pharmaceutical Company User's Perspective on the Potential of High Content Screening in Drug Discovery’, Humana Press eBooks, 356, pp. 19–32. doi:10.1385/1-59745-217-3:19.

IEEE

A. F. Hoffman and R. J. Garippa, “A Pharmaceutical Company User's Perspective on the Potential of High Content Screening in Drug Discovery,” Humana Press eBooks, vol. 356, pp. 19–32, 2006, doi: 10.1385/1-59745-217-3:19.

BibTeX

@incollection{hoffman2006pharmaceutical,
  title     = {{A Pharmaceutical Company User's Perspective on the Potential of High Content Screening in Drug Discovery}},
  author    = {Hoffman, Ann F. and Garippa, Ralph J.},
  booktitle = {Humana Press eBooks},
  publisher = {Humana Press},
  year      = {2006},
  volume    = {356},
  pages     = {19--32},
  doi       = {10.1385/1-59745-217-3:19},
  url       = {https://doi.org/10.1385/1-59745-217-3:19}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201222
201311
201411
201533
201622
201811

Its field-weighted citation impact is 6.20: it has been cited 6.20 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Biophysics › Cell Image Analysis Techniques

  • high-content screening
  • drug discovery
  • pharmaceutical industry
  • confocal microscopy
  • fluorescent probes
  • robotic automation
  • primary screening
  • cytotoxicity

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Hoffman, A. F., & Garippa, R. J. (2006). A Pharmaceutical Company User's Perspective on the Potential of High Content Screening in Drug Discovery. Humana Press eBooks, 356, 19–32. https://doi.org/10.1385/1-59745-217-3:19

How many times has this paper been cited?

34 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Ann F. Hoffman, Ralph J. Garippa.

What is the DOI of this paper?

10.1385/1-59745-217-3:19, permanently at https://doi.org/10.1385/1-59745-217-3:19. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.